Persons with organ transplants are at higher risk due to altered immune function. Burkitt's lymphoma in Africa is partly caused by the Epstein-Barr herpes virus. Other possible risk factors include occupational exposures to herbicides and perhaps other chemicals. Patients with later-stage disease often benefit from the addition of chemotherapy. New programs using highly specific monoclonal antibodies directed at lymphoma cells, and high-dose chemotherapy with bone marrow transplantation, are being investigated in selected patients who relapse after standard treatment.
Survival rates vary widely by cell type and stage of disease.
Lymphoma A list of links and information from Oncolink. Founded by non-Hodgkin's survivor Ellen Glesby Cohen in 1991, the Foundation has funded 58 lymphoma research projects at top universities and cancer centers in the U.S. since its inception. Grant applications are evaluated for scientific excellence and applicability to lymphoma by a prestigious Scientific Review Committee. The Lymphoma Research Foundation Canada seeks to provide support for those who face lymphoma and to those who undertake research in the diagnosis, treatment, and cure of lymphoma. Adult non-Hodgkin's Lymphoma From CancerNet from the National Cancer Institute.